The store will not work correctly when cookies are disabled.
(E)-1-(5-butylpyrazin-2-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one
ID: ALA2288838
PubChem CID: 6474707
Max Phase: Preclinical
Molecular Formula: C18H20N2O3
Molecular Weight: 312.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCc1cnc(C(=O)/C=C/c2ccc(O)c(OC)c2)cn1
Standard InChI: InChI=1S/C18H20N2O3/c1-3-4-5-14-11-20-15(12-19-14)16(21)8-6-13-7-9-17(22)18(10-13)23-2/h6-12,22H,3-5H2,1-2H3/b8-6+
Standard InChI Key: TWUVVIIJHPCWPI-SOFGYWHQSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
26.5532 -2.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5520 -2.8212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2601 -3.2302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9697 -2.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9669 -1.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2583 -1.5928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6731 -1.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3823 -1.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6700 -0.7696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.0885 -1.5815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7977 -1.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7977 -2.8035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5061 -3.2093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2133 -2.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2075 -1.9766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4986 -1.5744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9122 -1.5628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.6229 -1.9663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9230 -3.2030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8440 -3.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8433 -4.0464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1353 -4.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4279 -4.0453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
17 18 1 0
14 19 1 0
2 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.37 | Molecular Weight (Monoisotopic): 312.1474 | AlogP: 3.43 | #Rotatable Bonds: 7 |
Polar Surface Area: 72.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.50 | CX Basic pKa: 0.02 | CX LogP: 3.10 | CX LogD: 3.10 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: 0.11 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |